Cellular FLIP long isoform transgenic mice overcome inherent Th2-biased immune responses to efficiently resolve Leishmania major infection

Abstract

c-FLIPL expression in T cells is required for mounting effective T cell responses and can also be critical for effector T cell differentiation, as has recently been shown by a number of in vivo studies in conditional knockout and transgenic mouse systems. Available data supports therefore a novel immunomodulatory role of this anti-apoptotic protein besides its traditionally proposed function in homeostatic maintenance of T cell populations. In this study, the responses to infection with Leishmania major of mice over-expressing FLIPL specifically in the T cell compartment (TgFLIPL) are assessed. Although previous studies have shown that FLIPL drives T cells towards a Th2 differentiation programme in various autoimmune and allergic paradigms, in this study, we show that TgFLIPL are able to overcome this Th2 bias in a dermal L. major infection model to mount a robust Th1 response to pathogen and effectively clear infection. Our results suggest that vaccination protocols designed to enhance FLIPL expression in T cells may be useful for the treatment of autoimmune diseases like multiple sclerosis, without necessarily compromising immune responses towards infectious agents. © The Author 2007. Published by Oxford University Press on behalf of The Japanese Society for Immunology. All rights reserved.